These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38287814)

  • 21. Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease.
    Olivieri O; Chiariello C; Martinelli N; Castagna A; Speziali G; Girelli D; Pizzolo F; Bassi A; Cecconi D; Robotti E; Manfredi M; Conte E; Marengo E
    Clin Chem Lab Med; 2018 Aug; 56(9):1542-1550. PubMed ID: 29652662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-glycomic profiling of colorectal cancer according to tumor stage and location.
    Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
    PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
    Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
    PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum
    Moran AB; Elgood-Hunt G; van der Burgt YEM; Wuhrer M; Mesker WE; Tollenaar RAEM; Spencer DIR; Lageveen-Kammeijer GSM
    Biomolecules; 2023 May; 13(6):. PubMed ID: 37371476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialic acid linkage-specific permethylation for improved profiling of protein glycosylation by MALDI-TOF MS.
    Jiang K; Zhu H; Li L; Guo Y; Gashash E; Ma C; Sun X; Li J; Zhang L; Wang PG
    Anal Chim Acta; 2017 Aug; 981():53-61. PubMed ID: 28693729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes.
    Krishnan S; Shimoda M; Sacchi R; Kailemia MJ; Luxardi G; Kaysen GA; Parikh AN; Ngassam VN; Johansen K; Chertow GM; Grimes B; Smilowitz JT; Maverakis E; Lebrilla CB; Zivkovic AM
    Sci Rep; 2017 Mar; 7():43728. PubMed ID: 28287093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
    Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
    Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health.
    Reiding KR; Ruhaak LR; Uh HW; El Bouhaddani S; van den Akker EB; Plomp R; McDonnell LA; Houwing-Duistermaat JJ; Slagboom PE; Beekman M; Wuhrer M
    Mol Cell Proteomics; 2017 Feb; 16(2):228-242. PubMed ID: 27932526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
    Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
    Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous Quantification of Apolipoprotein C-III
    Kim H; Cheon DH; Yang WS; Baek JH
    J Proteome Res; 2023 Jan; 22(1):91-100. PubMed ID: 36412001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
    Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
    J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
    Liu C; Pan C; Shen J; Wang H; Yong L
    Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
    Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
    Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput Serum
    Reiding KR; Bondt A; Hennig R; Gardner RA; O'Flaherty R; Trbojević-Akmačić I; Shubhakar A; Hazes JMW; Reichl U; Fernandes DL; Pučić-Baković M; Rapp E; Spencer DIR; Dolhain RJEM; Rudd PM; Lauc G; Wuhrer M
    Mol Cell Proteomics; 2019 Jan; 18(1):3-15. PubMed ID: 30242110
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects.
    Rodríguez M; Rehues P; Iranzo V; Mora J; Balsells C; Guardiola M; Ribalta J
    J Proteomics; 2022 Jan; 251():104398. PubMed ID: 34688878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions.
    Mendoza S; Trenchevska O; King SM; Nelson RW; Nedelkov D; Krauss RM; Yassine HN
    J Clin Lipidol; 2017; 11(1):224-233.e2. PubMed ID: 28391889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A semi-automated, high throughput approach for O-glycosylation profiling of in vitro established cancer cell lines by MALDI-FT-ICR MS.
    Kotsias M; Madunić K; Nicolardi S; Kozak RP; Gardner RA; Jansen BC; Spencer DIR; Wuhrer M
    Glycoconj J; 2021 Dec; 38(6):747-756. PubMed ID: 34283362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved and semi-automated reductive β-elimination workflow for higher throughput protein O-glycosylation analysis.
    Kotsias M; Kozak RP; Gardner RA; Wuhrer M; Spencer DIR
    PLoS One; 2019; 14(1):e0210759. PubMed ID: 30653606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
    Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
    Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential
    Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
    Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.